Showing 5861-5870 of 9331 results for "".
- Psoriasis Myths, Stigmas Aboundhttps://practicaldermatology.com/news/myths-stigmas-about-psoriasis-abound/2457628/Stigmatizing views and myths about psoriasis are pervasive among the general population and medical students in the United States, according to multidisciplinary research from the Perelman School of Medicine at the University of Pennsylvania. The findings
- Compulink Launches Advantage SMART Practice Suite of AI Solutionshttps://practicaldermatology.com/news/compulink-launches-advantage-smart-practice-suite-of-ai-solutions/2457629/Compulink Healthcare Solutions rolled out new artificial intelligence (AI)-enabled features in a release its calling Advantage SMART Practice. Advantage uses AI technology and real-time data from the clinic to completely automate tasks such as billing, along with eliminating steps to improve pati
- FDA Accepts Ortho Derm's Resubmission of NDA for Duobrii Lotion for Plaque Psoriasishttps://practicaldermatology.com/news/fda-accepts-ortho-derms-resubmission-of-nda-for-duobrii-lotion-for-plaque-psoriasis/2457630/The FDA has accepted Ortho Dermatologics' resubmitted New Drug Application (NDA) for Duobrii (halobetasol propionate and tazarotene) (IDP-118) Lotion for the topical treatment of plaque psoriasis. The FDA accepted the application as a Class 2 resubmission, with a PDUFA action date of Feb. 15,
- General Medicine Update: Daily Aspirin May Not Work Wonders After Allhttps://practicaldermatology.com/news/general-medicine-update-daily-aspirin-may-not-work-wonders-after-all/2457633/It remains unclear whether daily aspirin lowers the risk of a cardiovascular event in individuals at moderate risk of a first heart attack or stroke, according to late-breaking results from the ARRIVE study presented at the European Society of Cardiology (ESC) Congress 2018 a
- FDA Nod for Ortho Derm's Acne Lotion Altrenohttps://practicaldermatology.com/news/fda-nod-for-ortho-derms-acne-lotion-altreno/2457635/The U.S. Food and Drug Administration (FDA) approved the New Drug Application for Ortho Dermatologic’s Altreno (tretinoin 0.05%) lotion, indicated for the topical treatment of acne vulgaris in patients aged 9 and up. Altreno is expected to be
- FDA Adds Four Tropical Diseases to Priority Review Voucher Programhttps://practicaldermatology.com/news/fda-adds-four-tropical-diseases-to-priority-review-voucher-program/2457639/The FDA announced the addition of Lassa fever, chikungunya virus disease, rabies and cryptococcal meningitis to the list of tropical diseases.
- Researchers Identify Cause of Aggressive SCCs in Recessive Dystrophic Epidermolysis Bullosahttps://practicaldermatology.com/news/researchers-identify-cause-of-aggressive-sccs-in-recessive-dystrophic-epidermolysis-bullosa/2457636/Immune system-related enzymes contribute significantly to the development of aggressive and fatal squamous cell carcinomas early in the life of individuals with recessive dystrophic epidermolysis bullosa (RDEB), an international team of scientists led by researchers at the Sidney Kimmel Canc
- Wake Forest Researchers: #2 in Probiotic Advancementhttps://practicaldermatology.com/news/wake-forest-researchers-2-in-probiotic-advancements/2457638/Scientists at Wake Forest School of Medicine say they have developed a probiotic “cocktail” derived from gut bacteria strains found in infant feces that may help increase the body’s ability to produce short-chain fatty acids (SCFAs). “Short-chain fa
- Melanoma Research Alliance Seeks Proposals, Funding Availablehttps://practicaldermatology.com/news/melanoma-research-alliance-seeks-proposals-funding-available/2457643/The Melanoma Research Alliance (MRA) is sol
- Special to Practical Dermatology: ACS Chief Medical Officer Sounds Off On Sunscreen Misusehttps://practicaldermatology.com/news/special-to-practical-dermatology-acs-chief-medical-officer-sounds-off-on-sunscreen-misuse/2457647/We are getting it all wrong when it comes to our reliance on sunscreen as the be all and end all protection from skin cancer, says Otis W. Brawley, MD, chief medical and scientific officer for the American Cancer Society in Atlanta. Sunscreen wasn’t developed so we could all get a f